Zdrowie i gospodarka · 14/07/2009

FDA Releases Guidance on Reporting Adverse Events for Nonprescription Human Drugs

The Food and Drug Administration (FDA) has published a guidance document outlining the requirements for reporting postmarketing serious adverse events for nonprescription human drugs that were marketed without prior FDA approval.